<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Buckley, Rita</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Hylek, Elaine M.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Anticoagulant Treatment Requires Special Care in the Elderly</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2013-08-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">30-30</style></pages><abstract><style  face="normal" font="default" size="100%">Atrial fibrillation (AF) is a leading reason for physicians to prescribe warfarin treatment in the elderly. The prevalence of AF increases with age [Chen LY, Shen WK. Heart Rhythm 2007]. By 2050, the projected number of persons with AF in the United States will exceed 10 million [Miyasaka Y et al. Circulation 2006], and 12%, or 1 in 8 Americans, will be aged =75 years. This article discusses the need to optimize anticoagulant treatment in the elderly.</style></abstract><number><style face="normal" font="default" size="100%">13</style></number><volume><style face="normal" font="default" size="100%">13</style></volume></record></records></xml>